🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Influence of Superficial Parasternal Intercostal Plane Block on Internal Thoracic Artery Caliber to Facilitate Surgical Harvesting in CABG

RecruitingPhase 3Ages 22 Years - 65 YearsAllAin Shams University
NCT07663435 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Influence of Superficial Parasternal Intercostal Plane Block (SPIPB) on Internal Thoracic Artery (ITA) Caliber and Surgical Harvesting Efficiency in Coronary Artery Bypass Grafting (CABG)

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Age group: Adult patients from age of 22 to 65 years. * Sex: Both sexes * Patients undergoing CABG with IMA harvesting Exclusion Criteria: * • Patients with pre-existing active bloodstream infection or systemic infection * Refuse consent * IMA graft not suitable * Morbidly obese (BMI \> 40 ) * Hemodynamic instability * Severe pulmonary disease * Previous thoracic surgeries (makes it difficult to harvest IMA) * Advanced malignancy or chronic disease with life expectancy less than six months * Emergency surgery
💊

What it tests

  • Bupivacaine
📍

Where

1 site
Faculty of Medicine ,Ain Shams University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy